HAEGENDORF, Switzerland--(BUSINESS WIRE)--Sensile Medical AG has completed the usability study for the semi-disposable patch pump that is developed for scPharmaceuticals LLC’s novel subcutaneous furosemide therapy. In the study health care professionals (HCPs) from seven hospitals in the United States and The Netherlands responded to questions about the subcutaneous application of furosemide (scFurosemide®) in the treatment of heart failure and the handling of Sensile Medical’s new patch pump. The HCPs identified a broad range of clinical situations where scFurosemide treatment may improve both, the care process as well as patients’ outcomes.
Help employers find you! Check out all the jobs and post your resume.
